NAIK v. BOEHRINGER INGELHEIM PHARMACEUTICALS INCORPORATED ... was fired by his employer, Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI), ... 621 et seq., and Title VII of the Civil Rights Act of 1964, 42 U.S.C. §§ 2000e et seq. ... At a sales meeting in early 2005, Somers informed all district managers that ...
Knight et al v. Boehringer Ingelheim Pharmaceuticals, Inc., No. 3:2015cv06424 - Document 118 (S.D.W. Va. 2018) case opinion from the Southern District of ...
Dec 7, 2016 ... BOEHRINGER INGELHEIM PHARMACEUTICALS INC. et al v. HEC PHARM CO. , LTD. et al, No. 3:2015cv05982 - Document 388 (D.N.J. 2016) ...
Aug 28, 2014 ... Kenneth R. Watterson,1 Brian D. Hudson,1 Trond Ulven,2 and ..... Sanofi and Boehringer-Ingelheim are also reported to have FFA1 .... Ltd, IRM LLC USA, Metabolex, Inc., Kindex Therapeutics, and Pharma Frontier Co., Ltd have all .... Ferdaoussi M, Bergeron V, Zarrouki B, Kolic J, Cantley J, Fielitz J, et al.
Dec 10, 2010 ... 5 advanced NCEs from the project  (BI1-BI5, see Roth et al.) .... All previously selected genes (TGF-β stim. vs. unstimulated cells, Fig. ...... KG DM, LM and LG are employees of Boehringer Ingelheim Pharmaceuticals Inc. This does not alter the authors' adherence .... Chico LK, Van Eldik LJ, Watterson DM.
Jul 30, 2015 ... Boehringer Ingelheim Pharma GmbH & Co. ... KG, a company developing drugs for the treatment of chronic obstructive pulmonary disease (COPD). ...... Waisman D, Brod V, Wolff R, Sanop E, Chernin M, Weintraub Z, et al. Effects of ..... Rossi JL, Velentza AV, Steinhorn DM, Watterson DM, Wainwright MS.
School of Pharmacy, University of Otago, Dunedin, New Zealand. Abstract. .... V. Antibodies . .... et al., 1993) and is expressed predominantly in immune ...... Birke F and Stiasni M (1989) inventors, Boehringer Ingelheim Kg, assignee. .... Christiansen E, Watterson KR, Stocker CJ, Sokol E, Jenkins L, Simon K, Grundmann.
All coated prostheses reduced bacterial growth drastically over 24 h, even below ... drug binding is the incorporation of drugs into biodegradable polymer ... (a) PDLLA. Resomer R203H, purchased from Boehringer Ingelheim (In- .... by ITEM GmbH—The Biotooling Company (Garching, Germany) and were ... MATL ET AL.
Jul 5, 2016 ... LDK378 (ceritinib, Zykadia; Novartis Pharmaceuticals, Basel, ..... funding from AstraZeneca/MedImmune and Boehringer Ingelheim. ... that was sponsored by Astellas Pharma Inc. The patient described in this report ... D.R., Hornick, J.L., Dal Cin, P., Antonescu, C.R., Jhanwar, S.C. et al. .... Gounant, V. et al.